James Rolke - Net Worth and Insider Trading
James Rolke Net Worth
The estimated net worth of James Rolke is at least $474,773 dollars as of 2024-11-13. James Rolke is the Chief Scientific Officer of La Jolla Pharmaceutical Co and owns about 76,330 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $474,773. Details can be seen in James Rolke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Rolke has not made any transactions after 2019-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Rolke
James Rolke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Rolke owns 2 companies in total, including La Jolla Pharmaceutical Co (LJPC) , and Revelation Biosciences Inc (REVB) .
Click here to see the complete history of James Rolke’s form 4 insider trades.
Insider Ownership Summary of James Rolke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LJPC | La Jolla Pharmaceutical Co | 2019-01-09 | Chief Scientific Officer |
| REVB | Revelation Biosciences Inc | 2022-01-10 | director & Chief Executive Officer |
James Rolke Latest Holdings Summary
James Rolke currently owns a total of 1 stock. James Rolke owns 76,330 shares of La Jolla Pharmaceutical Co (LJPC) as of January 9, 2019, with a value of $474,773.
Latest Holdings of James Rolke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LJPC | La Jolla Pharmaceutical Co | 2019-01-09 | 76,330 | 6.22 | 474,773 |
Holding Weightings of James Rolke
James Rolke Form 4 Trading Tracker
According to the SEC Form 4 filings, James Rolke has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 1,600 shares on January 9, 2019, which cost James Rolke around $9,744.
Insider Trading History of James Rolke
- 1
James Rolke Trading Performance
GuruFocus tracks the stock performance after each of James Rolke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Rolke is -7.37%. GuruFocus also compares James Rolke's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Rolke within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Rolke's insider trading performs compared to the benchmark.
Performance of James Rolke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.49 | | | | | |
| Relative Return to S&P 500(%) | -11 | | | | | |
James Rolke Ownership Network
Ownership Network List of James Rolke
Ownership Network Relation of James Rolke
James Rolke Owned Company Details
What does La Jolla Pharmaceutical Co do?
Who are the key executives at La Jolla Pharmaceutical Co?
James Rolke is the Chief Scientific Officer of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , director & Chief Executive Officer Larry G. Edwards , and Chief Financial Officer Michael S Hearne .
La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.
La Jolla Pharmaceutical Co Insider Transactions
James Rolke Mailing Address
Above is the net worth, insider trading, and ownership report for James Rolke. You might contact James Rolke via mailing address: 10182 Telesis Court, 6th Floor, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
